Rise in paracetamol therapeutic errors in the community during the COVID-19 pandemic

Research output: Contribution to journalLetterOtherpeer-review

Abstract

Treatment guidelines for COVID-19 recommend basic analgesics/antipyretics such as paracetamol.1 Paracetamol therapeutic errors are associated with morbidity and mortality.2 The Victorian Poisons Information Centre (VPIC), the statewide poisons centre for Victoria, Australia, receives calls from members of the public for advice regarding errors made with medicines. Paracetamol therapeutic errors are usually accidental overdoses (e.g. double-dose, maximum daily dose exceeded, incorrectly measured liquid paracetamol, or use of two paracetamol-containing medicines). The aim of this research was to explore the impact of the COVID-19 pandemic on the number of paracetamol therapeutic error cases in the community (outside of hospitals) that were reported to VPIC.
Original languageEnglish
Pages (from-to)436-438
Number of pages3
JournalJournal of Pharmacy Practice and Research
Volume54
Issue number5
DOIs
Publication statusPublished - Oct 2024

Cite this